Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2000. Start Trial.
Date Value
September 30, 2026 98.84%
August 31, 2026 98.84%
July 31, 2026 98.84%
June 30, 2026 98.84%
May 31, 2026 98.84%
April 30, 2026 98.84%
March 31, 2026 98.84%
February 28, 2026 98.84%
January 31, 2026 98.84%
December 31, 2025 98.84%
November 30, 2025 98.84%
October 31, 2025 98.84%
September 30, 2025 98.84%
August 31, 2025 98.84%
July 31, 2025 98.84%
June 30, 2025 98.84%
May 31, 2025 98.84%
April 30, 2025 98.84%
March 31, 2025 98.84%
February 28, 2025 98.02%
January 31, 2025 98.02%
December 31, 2024 98.02%
November 30, 2024 98.02%
October 31, 2024 96.77%
September 30, 2024 96.48%
Date Value
August 31, 2024 96.48%
July 31, 2024 96.18%
June 30, 2024 96.18%
May 31, 2024 96.18%
April 30, 2024 96.18%
March 31, 2024 91.86%
February 29, 2024 91.34%
January 31, 2024 91.34%
December 31, 2023 90.35%
November 30, 2023 90.35%
October 31, 2023 88.40%
September 30, 2023 83.74%
August 31, 2023 83.74%
July 31, 2023 83.74%
June 30, 2023 83.74%
May 31, 2023 83.74%
April 30, 2023 83.74%
March 31, 2023 83.74%
February 28, 2023 83.74%
January 31, 2023 83.74%
December 31, 2022 83.74%
November 30, 2022 83.74%
October 31, 2022 83.74%
September 30, 2022 83.74%
August 31, 2022 83.74%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Novavax, Inc. 98.82%
Amgen, Inc. 24.86%
BioCryst Pharmaceuticals, Inc. 79.10%
Imunon, Inc. 99.49%
Curis, Inc. 99.98%